Fasken Martineau DuMoulin LLP advised Exzell Pharma Inc. on the sale. On August 4, 2022, Exzell Pharma Inc. (“Exzell”), a Canadian pharmaceutical business, announced its sale...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here